SUBSCRIBERS
GSK eyes support from Singapore, Qatar for consumer healthcare division
Published Wed, Jan 19, 2022 · 05:50 AM
London
GLAXOSMITHKLINE (GSK) is spinning off its consumer healthcare division this year, and intends to seek support for the flotation from sovereign wealth funds and other major institutions.
A report in The Telegraph on Monday (Jan 17) said that Singapore and Qatar were regarded as potential "cornerstone investors".
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
‘Extreme’ climate blamed for world’s worst wine harvest in 62 years
Sheng Siong Q1 net profit up 9.3% on higher revenue
Nestle sales growth sputters on US slump, vitamin snags
Hermes Q1 sales jump 17% on strong China demand
Cordlife’s independent auditor to retire after issuing disclaimer of opinion on FY2023 financials
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO